Examining a Multicomponent Intervention to Improve HIV Health among Black Men in Southern Ending the HIV Epidemic in the U.S. Jurisdictions

检查改善南部黑人男性艾滋病毒健康的多成分干预措施,结束美国司法管辖区的艾滋病毒流行

基本信息

  • 批准号:
    10744410
  • 负责人:
  • 金额:
    $ 70.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Black men who have sex with men (BMSM) in the U.S. continue to experience a vastly inequitable HIV burden, particularly in Southern Ending the HIV Epidemic in the U.S. (EHE) jurisdictions. To combat this alarming trend, there is a need for innovative, accessible, and community-developed interventions to promote HIV health among BMSM in these areas. Given research that daily and multilevel intersectional stigma contributes to HIV inequities among BMSM, a multicomponent intervention that addresses multilevel barriers to HIV health and combats intersectional stigma is essential. In collaboration with THRIVE SS, a leading BMSM- led community-based organization serving BMSM living with HIV in the Atlanta area, we developed THRIVE365, an evidence-based multicomponent HIV intervention that provides individual-level health education and motivation, builds social support among BMSM, facilitates access to culturally-affirmative healthcare, and combats barriers to housing and economic empowerment in line with the Information- Motivation-Behavioral skills, social capital, and socioecological models of health. Pilot evidence indicates THRIVE365 is feasible, acceptable, and efficacious in promoting daily antiretroviral treatment (ART) adherence and reducing daily depressive symptoms, anxiety symptoms, and emotion regulation difficulties among BMSM living with HIV. THRIVE365 is ready for a full-scale evaluation guided by the RE-AIM framework that includes a robust examination of its effectiveness for HIV-related behavioral and psychological outcomes, its moderation effects on intersectional stigma, and its maintenance and reach over time. We will do so with a fully-powered hybrid type 2 implementation-effectiveness trial using daily diary methods, self-report follow-ups over 6 months, and paradata to examine daily and longer-term intervention engagement, effects, and adaptations. The overarching aims of this research are to: 1) Test the effectiveness of THRIVE365 in improving daily and longer-term HIV-related behavioral health (primary outcome: ART adherence) and psychological health (e.g., secondary outcomes: lower depressive and anxiety symptoms) in a 6-month waitlist randomized controlled trial with 350 BMSM living with HIV in the four Atlanta-area EHE jurisdictions; 2) Examine the moderating effect of THRIVE365 on associations between intersectional stigma and our primary and secondary HIV outcomes; 3) Evaluate THRIVE365 maintenance and reach at the user-level (e.g., within-user changes in engagement and daily effects) and setting-level (e.g., intervention adaptations, BMSM community uptake). Together, these results will establish the effectiveness of THRIVE365, a community-led, multicomponent intervention, for improving HIV-related behavioral and psychological health among BMSM living with HIV in four of the EHE jurisdictions with the greatest HIV burden. THRIVE365 was designed for implementation and is poised to offer a model for effective HIV care among BMSM in high-stigma, low-resource areas of the U.S. South and beyond.
项目总结/摘要 在美国,与男性发生性关系的黑人(BMSM)继续经历着非常不公平的艾滋病毒感染。 在美国结束艾滋病毒流行(EHE)管辖区。打击这一 由于这一趋势令人担忧,需要采取创新的、可获得的和社区开发的干预措施, 这些地区BMSM的艾滋病毒健康状况。研究表明,日常和多层次的交叉污名 导致BMSM中艾滋病毒的不平等,这是一种多成分干预措施, 艾滋病毒健康和打击交叉污名至关重要。在与繁荣SS,一个领先的BMSM合作- 领导的社区为基础的组织服务BMSM艾滋病毒感染者在亚特兰大地区,我们开发了 THRIVE 365是一种基于证据的多组分艾滋病毒干预措施,可提供个人层面的健康 教育和动机,在BMSM中建立社会支持,促进获得文化上的肯定 医疗保健,并打击住房和经济赋权的障碍,符合信息- 动机行为技能,社会资本,和健康的社会生态模型.飞行员的证据表明 THRIVE 365在促进每日抗逆转录病毒治疗(ART)依从性方面是可行、可接受和有效的 减少BMSM的日常抑郁症状、焦虑症状和情绪调节困难 艾滋病毒携带者THRIVE 365已准备好在RE-AIM框架的指导下进行全面评估,该框架包括 对艾滋病毒相关行为和心理结果的有效性进行了强有力的检查, 对交叉柱头的影响,以及随着时间的推移其维持和到达。我们将用一个充满动力的 采用每日日记法的混合2型实施-有效性试验,自我报告随访超过6 个月,并paradise检查日常和长期干预的参与,效果和适应。 本研究的总体目标是:1)测试THRIVE 365在改善日常生活和 长期HIV相关行为健康(主要结果:ART依从性)和心理健康(例如, 次要结果:较低的抑郁和焦虑症状)在6个月的等待名单随机对照试验 与350 BMSM艾滋病毒感染者在四个EHE地区管辖; 2)检查的调节作用, THRIVE 365关于交叉羞辱与我们的主要和次要艾滋病毒结果之间的关联; 3) 评估THRIVE 365维护并达到用户级别(例如,用户参与度的内部变化, 日常效果)和设置水平(例如,干预适应,BMSM社区吸收)。所有这些 结果将确定THRIVE 365的有效性,这是一种社区主导的多成分干预措施, 改善四个EHE中感染艾滋病毒的BMSM的艾滋病毒相关行为和心理健康 艾滋病负担最重的地区。THRIVE 365是为实施而设计的, 在美国南部及其他地区的高耻辱,低资源地区的BMSM中有效的艾滋病毒护理模式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Devin English其他文献

Devin English的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Devin English', 18)}}的其他基金

Measuring Daily Experiences of Racial Discrimination in African American Youth
衡量非裔美国青年种族歧视的日常经历
  • 批准号:
    8595972
  • 财政年份:
    2013
  • 资助金额:
    $ 70.09万
  • 项目类别:
Measuring Daily Experiences of Racial Discrimination in African American Youth
衡量非裔美国青年种族歧视的日常经历
  • 批准号:
    8896691
  • 财政年份:
    2013
  • 资助金额:
    $ 70.09万
  • 项目类别:
Measuring Daily Experiences of Racial Discrimination in African American Youth
衡量非裔美国青年种族歧视的日常经历
  • 批准号:
    8727996
  • 财政年份:
    2013
  • 资助金额:
    $ 70.09万
  • 项目类别:

相似海外基金

Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
  • 批准号:
    10098274
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
  • 批准号:
    2902083
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Launchpad
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
  • 批准号:
    MR/Z503599/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Research Grant
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
  • 批准号:
    MR/Y009460/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
  • 批准号:
    DP230101928
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
  • 批准号:
    10097862
  • 财政年份:
    2024
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Collaborative R&D
Application name Phase Space - VR hypnotherapy as early intervention for anxiety in students and young people
应用程序名称 Phase Space - VR 催眠疗法作为学生和年轻人焦虑的早期干预
  • 批准号:
    10055011
  • 财政年份:
    2023
  • 资助金额:
    $ 70.09万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了